Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases

Deregulated NF-k activation is not only involved in cancer but also contributes to the pathogenesis of chronic inflammatory diseases like rheumatoid arthritis (RA) and multiple sclerosis (MS). Ideally, therapeutic NF-KappaB inhibition should only take place in those cell types that are involved in d...

Descripción completa

Detalles Bibliográficos
Autores principales: Sehnert, Bettina, Burkhardt, Harald, Dübel, Stefan, Voll, Reinhard E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407293/
https://www.ncbi.nlm.nih.gov/pubmed/32640727
http://dx.doi.org/10.3390/cells9071627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407293/
https://www.ncbi.nlm.nih.gov/pubmed/32640727
http://dx.doi.org/10.3390/cells9071627

Ejemplares similares